Outcome Measures for Clinical Drug Trials in Autism

Abstract

This paper identifies instruments and measures that may be appropriate for randomized clinical trials in participants with autism spectrum disorders (ASDs HHS Public Access Author Manuscript Author ManuscriptAuthor Manuscript Author Manuscript scale was recommended for all randomized clinical trials. At this point, however, there is no "perfect" choice of outcome measure for core features of autism, although we will discuss five measures of potential utility. Several communication instruments are recommended, based in part on suitability across the age range. In trials where the intention is to alter core features of ASDs, adaptive behavior scales are also worthy of consideration. Several "behavior complexes" common to ASDs are identified, and instruments are recommended for assessment of these. Given the prevalence of cognitive impairment in ASDs, it is important to assess any cognitive effects, although cognitive data from ASD randomized clinical trials, thus far, are minimal. Guidance from trials in related pharmacologic areas and behavioral pharmacology may be helpful. We recommend routine elicitation of side effects, height and weight, vital signs, and (in the case of antipsychotics) extrapyramidal side-effects assessment. It is often appropriate to include laboratory tests and assessments for continence and sleep pattern.

Management of Children With Autism Spectrum Disorders

“…A wide variety of outcome measures have been used in research trials and in clinical practice to measure maladaptive behavior treatment effects. 199 Among the most common are the Clinical Global Impression Scale, Aberrant Behavior Checklist, and Nisonger Child Behavior Rating Form.…”

Risperidone Use in Autism Spectrum Disorders: A Retrospective Review of a Clinic-Referred Patient Population

“…14,15 Most clinical trials in the past 5 years have used clinician report of improvement based on the Clinical Global Impressions Scale (Global Improvement subscale). 16 The Global Improvement subscale requires the clinician to rate how much the patient's illness has improved or worsened relative to a baseline state. Although it is a 7-point scale, in the literature, the results are typically dichotomized into ''improved'' versus ''not improved'' in reporting success with therapy.…”

Evidence-Based Assessment of Autism Spectrum Disorders in Children and Adolescents

“…For these children, a traditional attention deficit hyperactivity disorder work-up is indicated (see Pelham, 2005). Measures such as continuous performance tests may be helpful to examine treatment response in such children (Aman et al, 2004).…”